Antifungal Resistance Testing and Implications for Management

Hamid Badali, Nathan P. Wiederhold

Research output: Contribution to journalReview article

Abstract

Purpose of Review: Antifungal agents are the mainstay in the management of patients with invasive fungal disease. However, resistance to current antifungal agents can develop with clinical use, which may negatively impact clinical outcomes. We review the strengths and weaknesses of antifungal susceptibility testing and how the detection of resistance, either phenotypically or molecularly, correlates with clinical outcomes. Recent Findings: Phenotypic resistance is associated with worse outcomes, although this must be taken in context with other patient factors. Newer molecular assays have been developed that have shown promising results for the detection of resistance mechanisms, including azole resistance in Aspergillus fumigatus and echinocandin resistance in different Candida species. Further work is needed to improve the clinical utility of these assays for faster turn-around-time and direct use on specimens. Summary: Detection of antifungal resistance may provide useful information for the treatment of invasive fungal disease.

Original languageEnglish (US)
JournalCurrent Fungal Infection Reports
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Mycoses
Antifungal Agents
Echinocandins
Azoles
Aspergillus fumigatus
Candida
Therapeutics

Keywords

  • Aspergillus
  • Azoles
  • Candida
  • Echinocandins
  • Invasive fungal disease
  • Mycoses

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Antifungal Resistance Testing and Implications for Management. / Badali, Hamid; Wiederhold, Nathan P.

In: Current Fungal Infection Reports, 01.01.2019.

Research output: Contribution to journalReview article

@article{9bd8647118cc4d34a0f1621132024063,
title = "Antifungal Resistance Testing and Implications for Management",
abstract = "Purpose of Review: Antifungal agents are the mainstay in the management of patients with invasive fungal disease. However, resistance to current antifungal agents can develop with clinical use, which may negatively impact clinical outcomes. We review the strengths and weaknesses of antifungal susceptibility testing and how the detection of resistance, either phenotypically or molecularly, correlates with clinical outcomes. Recent Findings: Phenotypic resistance is associated with worse outcomes, although this must be taken in context with other patient factors. Newer molecular assays have been developed that have shown promising results for the detection of resistance mechanisms, including azole resistance in Aspergillus fumigatus and echinocandin resistance in different Candida species. Further work is needed to improve the clinical utility of these assays for faster turn-around-time and direct use on specimens. Summary: Detection of antifungal resistance may provide useful information for the treatment of invasive fungal disease.",
keywords = "Aspergillus, Azoles, Candida, Echinocandins, Invasive fungal disease, Mycoses",
author = "Hamid Badali and Wiederhold, {Nathan P.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s12281-019-00354-6",
language = "English (US)",
journal = "Current Fungal Infection Reports",
issn = "1936-3761",
publisher = "Current Science, Inc.",

}

TY - JOUR

T1 - Antifungal Resistance Testing and Implications for Management

AU - Badali, Hamid

AU - Wiederhold, Nathan P.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Purpose of Review: Antifungal agents are the mainstay in the management of patients with invasive fungal disease. However, resistance to current antifungal agents can develop with clinical use, which may negatively impact clinical outcomes. We review the strengths and weaknesses of antifungal susceptibility testing and how the detection of resistance, either phenotypically or molecularly, correlates with clinical outcomes. Recent Findings: Phenotypic resistance is associated with worse outcomes, although this must be taken in context with other patient factors. Newer molecular assays have been developed that have shown promising results for the detection of resistance mechanisms, including azole resistance in Aspergillus fumigatus and echinocandin resistance in different Candida species. Further work is needed to improve the clinical utility of these assays for faster turn-around-time and direct use on specimens. Summary: Detection of antifungal resistance may provide useful information for the treatment of invasive fungal disease.

AB - Purpose of Review: Antifungal agents are the mainstay in the management of patients with invasive fungal disease. However, resistance to current antifungal agents can develop with clinical use, which may negatively impact clinical outcomes. We review the strengths and weaknesses of antifungal susceptibility testing and how the detection of resistance, either phenotypically or molecularly, correlates with clinical outcomes. Recent Findings: Phenotypic resistance is associated with worse outcomes, although this must be taken in context with other patient factors. Newer molecular assays have been developed that have shown promising results for the detection of resistance mechanisms, including azole resistance in Aspergillus fumigatus and echinocandin resistance in different Candida species. Further work is needed to improve the clinical utility of these assays for faster turn-around-time and direct use on specimens. Summary: Detection of antifungal resistance may provide useful information for the treatment of invasive fungal disease.

KW - Aspergillus

KW - Azoles

KW - Candida

KW - Echinocandins

KW - Invasive fungal disease

KW - Mycoses

UR - http://www.scopus.com/inward/record.url?scp=85074657750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074657750&partnerID=8YFLogxK

U2 - 10.1007/s12281-019-00354-6

DO - 10.1007/s12281-019-00354-6

M3 - Review article

AN - SCOPUS:85074657750

JO - Current Fungal Infection Reports

JF - Current Fungal Infection Reports

SN - 1936-3761

ER -